Complex Innovative Trial Designs (CID) have the potential to increase the efficiency and lower the cost of drug development, accelerating patient access to life-altering therapies. Through extensive scientific exchange among multidisciplinary stakeholders on CID designs and the PDUFA VI CID Pilot Program, complex adaptive design, Bayesian approaches, and innovative uses of alternative data sources, this is an exciting time to explore the value and use of CID in drug development programs.
To support continuous learning, DIA brings you complimentary digital downloads to spur thought, reflection, collaboration, and action. In your Resource Kit, you'll find links to intriguing articles from the DIA Global Forum and our peer-reviewed journal, Therapeutic Innovation & Regulatory Science (TIRS), exclusive podcast interviews, session recordings from DIA events, and more!
From RMB to RBx: The Keys to Successful Adoption and Implementation
Master Protocol Trials: From Innovation to Operationalization
Podcast: EU Clinical Trial Regulation Streamlines to "Matter of One"
Podcast: Defining Rational Medicine and Research at DIA Japan 2019
On Demand Webinar: Operationalizing Master Protocols Encore Presentation